摘要
目的观察聚精丸治疗少弱精子症患者的临床疗效。方法 125例少弱精子症患者随机分为对照组40例,治疗组85例。对照组患者服用VitE,100mg/次,2次/日;治疗组患者采用聚精丸治疗,每次5g,每日3次。2组分别在治疗前和治疗6个月后检测精液量、精子密度、a和b级精子、总活动率和妊娠率。结果 125例患者均完成治疗,2组均能增加患者的精液量、a级精子、前向运动精子、总活动率(P<0.05);治疗组还能显著提高患者的精子密度(P<0.05),在改善精子密度、a级精子、前向运动精子、精子总活动率和妊娠率方面优于对照组(P<0.05)。结论聚精丸能显著改善少弱精子症患者的精液质量,可以作为治疗不育症的药物之一。
OBJECTIVE To observe the clinical efficacy of Jujing Pill in treating oligospermia or asthenospermia. METH- ODS 125 cases of the oligospermia or asthenospermia patients were divided into control group （40 cases） and treatment group （85cases） at random. The control group took Vit E twice a day and 100 mg each time. The treatment group were treated by Jujing Pill one dose a day. The semen volume, semen density, a and b grade sperms, total motility rate and pregnant rate of the two groups were tested 6 months before and after treatment. RESULTS 125 patients all finished the treatment. Both two groups can increase patients＇ semen volume, a standard sperms, forward moving sperms and total motility rate （P〈0.05）. The treatment group could also improve the patients＇ semen density remarkably （P〈0.05） and was superior to control group in the improvement of semen density, a grade sperms and forward moving sperms, total motility rate and pregnant rate （P〈 0.05）. CONCLUTION Jujing Pill can significantly improve the semen quality of the oligospermia or asthenospermia patients and be used to treat sterility.
出处
《南京中医药大学学报》
CAS
CSCD
北大核心
2013年第1期92-93,共2页
Journal of Nanjing University of Traditional Chinese Medicine
基金
国家重点基础研究发展计划课题("973"计划)(2010CB530401)
国家自然科学基金(81273760/H2709)
关键词
聚精丸
少弱精子症
精液质量
Jujing Pill
oligospermia on asthenospermia
semen quality
